The iconic rise of Viagra has long been a symbol of pharmaceutical success, but its legacy within the broader market now presents questions about long-term gains. Generic versions are diminishing market share, leading to worries that investing in companies closely tied to Viagra's previous position could be a dangerous decision , especially given c